Pnc Financial Services Group, Inc. Bridge Bio Pharma, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,099 shares of BBIO stock, worth $40,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,099
Previous 1,952
43.7%
Holding current value
$40,498
Previous $49,000
38.78%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...